Williams Lewis T

CIK 00014757145 companiesNEWARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001475714

Recent Transactions

50 trades

Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2026-01-02+3,762→ 3,762 total
Award
Protagonist Therapeutics, Inc$PTGX
Common Stock
2026-01-02+2,695→ 7,825 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2025-01-02+6,584→ 6,584 total
Award
Protagonist Therapeutics, Inc$PTGX
Common Stock
2025-01-02+5,130→ 5,130 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2024-01-02+25,700→ 25,700 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2023-01-16+30,000→ 30,000 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2022-05-26+20,000→ 20,000 total
Conversion
Arcellx, Inc.$ACLX
Series B-2 Preferred Stock
2022-02-08−931,228→ 0 total
Conversion
Arcellx, Inc.$ACLX
Common Stock
2022-02-08+2,095,114→ 2,095,114 total
Conversion
Arcellx, Inc.$ACLX
Series B-1 Preferred Stock
2022-02-08−1,163,886→ 0 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2021-05-27+18,000→ 18,000 total
Award
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2021-05-11+25,000→ 25,000 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2020-05-28+15,000→ 15,000 total
Award
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2020-05-05+25,000→ 25,000 total
Award
Neurogene Inc.$NGNE
Stock Option (right to buy)
2019-10-10+22,000→ 22,000 total
Tax Payment
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2019-09-01$5.43/sh−7,024→ 455,336 total
Award
FIVE PRIME THERAPEUTICS, INC.
Stock Option (right to buy)
2019-06-10+15,000→ 15,000 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2019-06-07+12,000→ 12,000 total
Tax Payment
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2019-02-26$11.95/sh−926→ 461,360 total
Award
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2019-02-25+6,400→ 6,400 total
Award
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2019-02-25+1,000→ 462,360 total
Tax Payment
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2019-02-05$11.43/sh−3,144→ 462,286 total
Exercise/Conversion
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2018-11-05−91,217→ 0 total
Exercise/Conversion
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2018-11-05$4.56/sh+91,217→ 465,430 total
Tax Payment
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2018-09-01$14.00/sh−7,024→ 374,213 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2018-05-29+12,000→ 12,000 total
Award
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2018-02-26+30,000→ 30,000 total
Award
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2018-02-26+5,000→ 381,237 total
Tax Payment
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2018-02-05$18.42/sh−3,137→ 376,237 total
Tax Payment
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2017-09-01$34.34/sh−7,827→ 381,958 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2017-06-15+24,000→ 24,000 total
Tax Payment
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2017-03-01$44.77/sh−34,532→ 388,754 total
Award
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2017-02-07+16,875→ 423,286 total
Award
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2017-02-07+101,250→ 101,250 total
Tax Payment
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2017-01-03$48.60/sh−5,065→ 428,827 total
Sale
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2016-12-23$50.49/sh−29,700→ 434,192 total
Exercise/Conversion
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2016-12-23−10→ 16,349 total
Exercise/Conversion
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2016-12-23$4.56/sh+155→ 434,047 total
Sale
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2016-12-23$51.02/sh−300→ 433,892 total
Exercise/Conversion
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2016-12-23−29,816→ 31,159 total
Exercise/Conversion
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2016-12-23$6.89/sh+19→ 434,066 total
Exercise/Conversion
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2016-12-23−155→ 91,217 total
Exercise/Conversion
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2016-12-23$5.54/sh+29,816→ 463,892 total
Exercise/Conversion
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2016-12-23−19→ 14,438 total
Exercise/Conversion
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2016-12-23$8.49/sh+10→ 434,076 total
Gift
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2016-09-14−407→ 433,892 total
Gift
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2016-09-01$44.74/sh−22,416→ 434,299 total
Tax Payment
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2016-09-01$44.74/sh−7,613→ 456,715 total
Gift
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2016-09-01−22,416→ 406,411 total
Gift
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2016-09-01−0→ 428,827 total

Williams Lewis T

Recent Transactions

Companies

Recent Filings

Address